Pharmalink-AB

Médias

Pharmalink Initiates a Pivotal Phase IIb Trial with Nefecon® in Patients with Primary IgA Nephropathy

Médias

Pharmalink Enters Manufacturing Agreement for Busulipo™

Médias

Pharmalink Enters Manufacturing Agreement for Nefecon(R)

Médias

Pharmalink AB Strengthens Senior Management Team